Cognitive Behavioral Therapy for Parents of Children With Food Allergies
Trial Summary
What is the purpose of this trial?
Parents of children with food allergies that are medically established will be able to participate in 6 one-hour weekly virtual Cognitive Behavioral Therapy (CBT) groups, and outcomes will be measured for anxiety, depression and quality of life. Possible benefits include improvement in psychological functioning and quality of life of families, as well as improved understanding of the use of group Cognitive Behavioral Therapy (CBT) for parents of children with medically established food allergies.
Will I have to stop taking my current medications?
You can continue taking your current antidepressants or anxiety medications, but the doses must stay the same for one month before the study, during the study, and for two months after it ends. If your medications are being adjusted, you cannot participate.
What data supports the effectiveness of the treatment Cognitive Behavioral Therapy (CBT) for parents of children with food allergies?
Is Cognitive Behavioral Therapy (CBT) safe for parents of children with food allergies?
Cognitive Behavioral Therapy (CBT) is generally considered safe for humans and has been used to help reduce anxiety and stress in parents of children with food allergies. Studies have shown that therapists can be trained to deliver CBT effectively, and it can improve mental health and parenting behaviors without significant safety concerns.12467
How does the treatment Cognitive Behavioral Therapy (CBT) for parents of children with food allergies differ from other treatments?
Cognitive Behavioral Therapy (CBT) is unique because it focuses on reducing the psychological impact, such as stress and anxiety, that parents experience due to their child's food allergies, which can improve both the parents' and children's mental health. Unlike other treatments that might focus on the physical management of allergies, CBT addresses the emotional and mental well-being of the caregivers.12468
Research Team
Stephen Jarvis, MD
Principal Investigator
University Health Behavioral Health, and UMKC
Jessica Hellings, MD
Principal Investigator
University of Missouri-Kansas City and University Health Behavioral Health
Eligibility Criteria
This trial is for parents over 18 with a child aged 6-17 who has a serious food allergy diagnosed by a doctor. Parents should show signs of anxiety or depression but can be on stable medication for these conditions. They must commit to weekly sessions and follow-ups without current psychiatric treatment changes, substance abuse, or use of certain over-the-counter remedies.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in 6 weekly one-hour virtual Cognitive Behavioral Therapy (CBT) sessions
Follow-up
Participants complete follow-up questionnaires to assess retention of effect post-intervention
Treatment Details
Interventions
- CBT
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Missouri, Kansas City
Lead Sponsor